A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)
A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)
Recruiting · NCT05487170 · Registry updated 2025-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1) | diffuse large B-cell lymphoma | Recruiting | Phase 1 / Phase 2 | 2025-03-04 | NCT05487170 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ranok Therapeutics (Hangzhou) Co., Ltd. | 4 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Cancer Hospital, Chinese Academy of Medical Sciences | Beijing | China | 41 |
| Emory University Winship Cancer Institute | Atlanta | United States | 15 |
| Norton Cancer Institute | Louisville | United States | 26 |
| Weill Cornell - NY Presbyterian Hospital | New York | United States | 1 |